The LigaSure Curved, Small Jaw, Open Sealer/Divider instrument will be sold in the U.S. starting this quarter.
According to Covidien’s website, LigaSure technology can fuse vessels, including pulmonary vasculature, up to and including 7 mm, lymphatics and tissue bundles with an average seal cycle of two to four seconds.
Read the Boulder County Business Report on LigaSure.
Read more on device approval:
–FDA Approves EndoSerter Device for Corneal Transplants
–Weight Loss Centers Expect More Business Following FDA Lap-Band Decision
–Anesthesiology Devices Recalled After Weak Oversight by FDA
